Royal Biologics
PrivateLast Round
Early Funding
Jun 19, 2019
Company Overview
Royal Biologics is a medical devices company that manufactures and distributes orthobiologics, stem cell therapy devices, and spinal implant hardware.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Royal Biologics Comparables
Compare Royal Biologics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PRP Concepts | 86% | |
| Isto Biologics | 81% | |
| Reapplix | 76% |
Royal Biologics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 19, 2019 |
Key People
Founding team and executive leadership
Royal Biologics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Granite Creek Capital Partners | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Monthly visitors grew 479% MoM, reaching 4K.
- May 4, 2025
Monthly visitors increased 50% MoM.
Royal Biologics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Royal Biologics's valuation, stock price, and market status.
Is Royal Biologics a public or private company?
Royal Biologics is a private company.
What is the current stock price of Royal Biologics?
Royal Biologics is a private company with no public stock price. No recent secondary market data is available.
How much is Royal Biologics worth (valuation)?
Valuation information for Royal Biologics is not publicly available.
Can I buy Royal Biologics stock?
Royal Biologics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Royal Biologics's last funding round?
Royal Biologics's most recent funding round was Early Funding on June 19, 2019.
Who are the main investors in Royal Biologics?
Key investors in Royal Biologics include Granite Creek Capital Partners.
Will Royal Biologics IPO soon?
No public IPO plans have been announced for Royal Biologics.
How can I track Royal Biologics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Royal Biologics's secondary market activity and sign up for updates.